Publication Title ("BJU International") And Id (5JCC) And Date (Mar 01, 2022) And Issue Number ("3") And Volume Number (129) - Results

Select Understanding cultural and logistical contexts for urologists in low-income countries.

1

Understanding cultural and logistical contexts for urologists in low-income countries.

Authors:Nicholas Campain, Charles Mabedi, Vanessa Savopoulos, Stephen R. Payne, and Ruaraidh MacDonaghFrom:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022332 words Report, Brief articl...

Abstract Only

Select Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test.

2

Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test.

Authors:Thierry Lebret, Geraldine Pignot, Marc Colombel, Laurent Guy, Xavier Rebillard, Laurent Savareux, et al.From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022293 words Report, Brief articl...

Abstract Only

Select Online urological educational material for medical students: can search engines be trusted?

3

Online urological educational material for medical students: can search engines be trusted?

Authors:James Gunasegaram, Sean Ong, Ray Swann, and Nathan LawrentschukFrom:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022330 words Report, Brief articl...

Abstract Only

Select Bladder cancer risk variants and overall and disease-specific survival in two independent cohorts.

4

Bladder cancer risk variants and overall and disease-specific survival in two independent cohorts.

Authors:Reno C. Leeming, Margaret R. Karagas, Michael S. Zens, Alan R. Schned, John D. Seigne, and Michael N. PassarelliFrom:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 202228 words Report, Brief articl...

Abstract Only

Select New guidance regarding the diagnosis and risk stratification of patients with prostate cancer.

5

New guidance regarding the diagnosis and risk stratification of patients with prostate cancer.

From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 20229 words Report, Brief articl...

Abstract Only

Select Contribution of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP) to the ongoing debate on the value of prostate cancer screening.

6

Contribution of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP) to the ongoing debate on the value of prostate cancer screening.

Authors:Richard M. Martin, Padraig Dixon, Emma Turner, and Edna KeeneyFrom:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 202219 words Report, Brief articl...

Abstract Only

Select Case of the Month from UCSD, San Diego, USA: Treatment of giant dystrophic prostatic calcification using MOSES holmium laser.

7

Case of the Month from UCSD, San Diego, USA: Treatment of giant dystrophic prostatic calcification using MOSES holmium laser.

Authors:Austin J. Leonard, Nishant Garg, Tony T. Chen, and Manoj MongaFrom:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 202241 words Report, Brief articl...

Abstract Only

Select Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity.

8

Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity.

Authors:Achiraya Teyateeti, Craig Grossman, Marisa A. Kollmeier, Megan Fiasconaro, Margaret Hopkins, Sean McBride, et al.From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022305 words Report, Brief articl...

Abstract Only

Select Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy.

9

Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy.

Authors:Jordan G. Flitcroft, Jeroen Verheyen, Tarun Vemulkar, Emma N. Welbourne, Sabrina H. Rossi, Sarah J. Welsh, et al.From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022214 words Report, Brief articl...

Abstract Only

Select FDA approves the Optilume® urethral drug coated balloon for the treatment of urethral strictures.

10

FDA approves the Optilume® urethral drug coated balloon for the treatment of urethral strictures.

From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 20229 words Report, Brief articl...

Abstract Only

Select Assessment of prostate-specific antigen screening: an evidence-based report by the German Institute for Quality and Efficiency in Health Care.

11

Assessment of prostate-specific antigen screening: an evidence-based report by the German Institute for Quality and Efficiency in Health Care.

Authors:Ulrike Paschen, Sibylle Sturtz, Daniel Fleer, Ulrike Lampert, Nicole Skoetz, and Philipp DahmFrom:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022420 words Report

Abstract Only

Select Corrigendum.

12

Corrigendum.

From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 20229 words Correction notice, R...

Abstract Only

Select Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.

13

Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.

Authors:Jinge Zhao, Guangxi Sun, Sha Zhu, Jindong Dai, Junru Chen, Mengni Zhang, et al.From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022566 words Report

Abstract Only

Select The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography/computed tomography.

14

The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography/computed tomography.

Authors:Hans Veerman, Maarten Donswijk, Elise Bekers, Judith olde Heuvel, Yves J.L. Bodar, Thierry N. Boellaard, et al.From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 202244 words Report, Brief articl...

Abstract Only

Select The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study.

15

The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study.

Authors:Johan Björklund, Pär Stattin, Erik Rönmark, Markus Aly, and Olof AkreFrom:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022350 words Report, Brief articl...

Abstract Only

Select Masculinizing surgery in disorders/differences of sex development: clinician- and participant-evaluated appearance and function.

16

Masculinizing surgery in disorders/differences of sex development: clinician- and participant-evaluated appearance and function.

Authors:Tim C. van de Grift, Marion Rapp, Gundela Holmdahl, Lise Duranteau, Agneta Nordenskjold, Birgit Kohler, et al.From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022384 words Report, Brief articl...

Abstract Only

Select The association between modifiable perioperative parameters and renal function after nephrectomy.

17

The association between modifiable perioperative parameters and renal function after nephrectomy.

Authors:Roy Mano, Amy L. Tin, Andrew W. Silagy, Samuel C. Haywood, Chun Huang, Nicole E. Benfante, et al.From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022510 words Report

Abstract Only

Select A nationwide trend away from radical prostatectomy for Gleason Grade Group 1 prostate cancer.

18

A nationwide trend away from radical prostatectomy for Gleason Grade Group 1 prostate cancer.

Authors:Joseph B. John, John Pascoe, Sarah Fowler, Thomas Walton, Mark Johnson, Benjamin Challacombe, et al.From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 202231 words Report, Brief articl...

Abstract Only

Select A randomized trial investigating clinical outcomes and stent-related symptoms after placement of a complete intra-ureteric stent on a string versus conventional stent placement.

19

A randomized trial investigating clinical outcomes and stent-related symptoms after placement of a complete intra-ureteric stent on a string versus conventional stent placement.

Authors:Milap Shah, Sunil Pillai, Arun Chawla, Jean J. M. C. H. Rosette, Pilar Laguna, Suraj Jayadeva Reddy, et al.From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022342 words Report, Brief articl...

Abstract Only

Select The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.

20

The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.

Authors:Sarah Benafif, Holly Ni Raghallaigh, Eva McGrowder, Edward J. Saunders, Mark N. Brook, Sibel Saya, et al.From:BJU International (Vol. 129, Issue 3) Peer-Reviewed

Mar. 2022499 words Report

Abstract Only

Open Access User

Library Information

Showing Results for

Search Results

Academic Journals

Understanding cultural and logistical contexts for urologists in low-income countries.

Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test.

Online urological educational material for medical students: can search engines be trusted?

Bladder cancer risk variants and overall and disease-specific survival in two independent cohorts.

New guidance regarding the diagnosis and risk stratification of patients with prostate cancer.

Contribution of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP) to the ongoing debate on the value of prostate cancer screening.

Case of the Month from UCSD, San Diego, USA: Treatment of giant dystrophic prostatic calcification using MOSES holmium laser.

Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity.

Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy.

FDA approves the Optilume® urethral drug coated balloon for the treatment of urethral strictures.

Assessment of prostate-specific antigen screening: an evidence-based report by the German Institute for Quality and Efficiency in Health Care.

Corrigendum.

Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.

The clinical characteristics of patients with primary non-prostate-specific membrane antigen-expressing prostate cancer on preoperative positron emission tomography/computed tomography.

The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study.

Masculinizing surgery in disorders/differences of sex development: clinician- and participant-evaluated appearance and function.

The association between modifiable perioperative parameters and renal function after nephrectomy.

A nationwide trend away from radical prostatectomy for Gleason Grade Group 1 prostate cancer.

A randomized trial investigating clinical outcomes and stent-related symptoms after placement of a complete intra-ureteric stent on a string versus conventional stent placement.

The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.

Filter Your Results